InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,644.00
(
0.68%
)
Dow Jones
40,589.34
(
0.00%
)
Brent Oil
80.01
(
-0.71%
)
Bitcoin
69,448.32
(
2.43%
)
Post# of 7996
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

benchman

Send PM Follow Ignore
Followers 153
Posts 20214
Boards Moderated 1
Alias Born 08/10/2005

benchman

Member Level

Re: None

Tuesday, 03/01/2016 1:20:14 PM

Tuesday, March 01, 2016 1:20:14 PM

Post# of 7996
PTCT - For people wondering about this one: The stock was at $30 on Feb 22. That evening or the next morning, they received a refuse to file letter from the FDA on their main drug. While this is not good, the company is going to tray and work it out with the FDA. That being said, the company is making millions off of it in other countries. Additionally, they have something like $330 million in cash. Lastly, this is not their only drug.

Based on that information, you have to think this sell off from $30 to $5.66 is way over done.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up